Oncology, Hadassah Hebrew University Medical Center, EIn Kerem POB 12000, 91120 Jerusalem, Israel.
Int J Biochem Cell Biol. 2010 May;42(5):551-4. doi: 10.1016/j.biocel.2009.12.015. Epub 2009 Dec 22.
Mast cells are evolutionarly ancient cells of the immune cells which can secrete a variety of effector molecules. Animal and pathologic studies suggest that mast cells may promote tumor growth in some cancer types but may act in an opposite manner in others. In several mouse models a critical role of mast cells for tumor promotion was demonstrated. In humans mast cells are dependent upon the tyrosine kinase receptor c-Kit. This receptor is inhibited by many of the new anti-cancer tyrosine kinase inhibitors including Pazopanib, Imatinib and Masitinib. These drugs probably ablate some tumor mast cells, in addition to their other known antitumor effects. Understanding the complex roles of mast cells in cancer should aid in understanding mechanisms of current tyrosine kinase inhibitors, and the development of innovative anti-cancer therapies.
肥大细胞是进化古老的免疫细胞,能够分泌多种效应分子。动物和病理研究表明,肥大细胞可能在某些癌症类型中促进肿瘤生长,但在其他癌症类型中可能表现出相反的作用。在几种小鼠模型中,已经证明了肥大细胞在肿瘤促进中的关键作用。在人类中,肥大细胞依赖于酪氨酸激酶受体 c-Kit。该受体被许多新型抗癌酪氨酸激酶抑制剂抑制,包括帕唑帕尼、伊马替尼和马替尼。除了其已知的抗肿瘤作用外,这些药物可能还会消除一些肿瘤肥大细胞。了解肥大细胞在癌症中的复杂作用应该有助于理解当前酪氨酸激酶抑制剂的作用机制,并开发创新的抗癌疗法。